Artículos mes de Mayo 2011

No mostrar en "slideshow"

Enlace a algunos de los artículos ya publicados para este mes de Mayo. Estenosis del stent, antiagregantes nuevos para la patología isquémica miocárdica: Prasugrel; uso del factor VIIa, Clostridium Difficile, descontaminación selectiva, PCO2 destete de la ventilación mecánica, y un suplemento especial del Clinical Infectious Disease sobre las infecciones urinarias por Cándida. Estos son los artículos a los que se puede acceder.

Restenosis: Delineating the Numerous Causes of Drug-Eluting Stent Restenosis. [1]

Vasim Farooq, Bill D. Gogas, and Patrick W. Serruys

Circ Cardiovasc Interv 2011;4 195-205.

CO2 Response and Duration of Weaning From Mechanical Ventilation. [2]

Raurich JM, Rialp G, Ibáñez J, Llompart-Pou JA, Ayestarán I.

Respir Care. 2011 Apr 15.

Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications. [3]

Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS.

Ann Intern Med. 2011 Apr 19;154(8):529-40.

High Doses of Clopidogrel to Overcome Genetic Resistance The Randomized Crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). [4]

Collet JP, Hulot JS, Anzaha G, Pena A, Chastre T, Caron C, Silvain J, Cayla G, Bellemain-Appaix A, Vignalou JB, Galier S, Barthélémy O, Beygui F, Gallois V, Montalescot G; CLOVIS-2 Investigators.

JACC Cardiovasc Interv. 2011 Apr;4(4):392-402.

Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel The Importance of CYP2C19*2 Genotyping. [5]

Alexopoulos D, Dimitropoulos G, Davlouros P, Xanthopoulou I, Kassimis G, Stavrou EF, Hahalis G, Athanassiadou A.

JACC Cardiovasc Interv. 2011 Apr;4(4):403-410.

Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. [6]

Barbut F, Jones G, Eckert C.

Curr Opin Infect Dis. 2011 Apr 19.

Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study [7]

Anne Marie GA de Smet, Jan AJW Kluytmans, Hetty EM Blok, Ellen M Mascini, Robin FJ Benus, Alexandra T Bernards, Ed J Kuijper, Maurine A Leverstein-van Hall, Arjan R Jansz, Bartelt M de Jongh, Gerard J van Asselt, Ine HME Frenay, Steven FT Thijsen, Simon NM Conijn, Jan A Kaan, Jan P Arends, Patrick DJ Sturm, Martin CJ Bootsma, Marc JM Bonten

Lancet Infectious disease. 2011 May; (11) 5: 372-380.

CandidaUrinary Tract Infections

Candida Urinary Tract Infections—Epidemiology, Pathogenesis, Diagnosis, and Treatment: Executive Summary. [8]

John F. Fisher

Clin Infect Dis. (2011) 52(suppl 6): S429-S432

Candida Urinary Tract Infections—Epidemiology [8]

Jack D. Sobel, John F. Fisher, Carol A. Kauffman, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S433-S436

Candida Urinary Tract Infection: Pathogenesis [8]

John F. Fisher, Kevin Kavanagh, Jack D. Sobel, Carol A. Kauffman, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S437-S451

Candida Urinary Tract Infections—Diagnosis [8]